marijuana stocks news

Indie Growers Association Inc. (UPOT)

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 44   29   –   –  
Cost of Revenue – – – –
Gross Profit 44   29   –   –  
Operating Expenses
Research Development – – – –
Selling General and Administrative 14 45 48,400 107
Non Recurring – – – –
Others – – – –
Total Operating Expenses – – – –
Operating Income or Loss 30   3,024   (51,439) (107)
Income from Continuing Operations
Total Other Income/Expenses Net – (61,813) (3,038) –
Earnings Before Interest And Taxes 30 3,024 (51,439) (107)
Interest Expense – (1) 1 –
Income Before Tax 30 3,025 (51,441) (107)
Income Tax Expense – – – –
Minority Interest – – – –
Net Income From Continuing Ops 30 (58,787) (54,479) (107)
Non-recurring Events
Discontinued Operations – – – –
Extraordinary Items – – – –
Effect Of Accounting Changes – – – –
Other Items – – – –
Net Income 30   (61,827) (51,439) (107)
Preferred Stock And Other Adjustments – – – –
Net Income Applicable To Common Shares 30   (61,827) (51,439) (107)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Integrated Cannabis Company, Inc. (ICNAF) to Acquire Assets of Colorado-Based Cannabis Innovator, Critical Mass Industries, LLC

Integrated Cannabis Company, Inc. to Acquire Assets of Colorado-Based Cannabis Innovator, Critical…

Premier Health Group (PHGI) (PHGRF) and CB2 Insights Move to Second Phase of Primary Care Physician Tools for Medical Cannabis Evaluation

Premier Health and CB2 Insights Move to Second Phase of Primary Care…

AbbVie Inc. (ABBV) Second Phase 3 Induction Study Confirms Upadacitinib (RINVOQ®) Improved Clinical and Endoscopic Outcomes

Second Phase 3 Induction Study Confirms Upadacitinib (RINVOQ®) Improved Clinical and Endoscopic…

Tilray Brands, Inc. (TLRY) to Announce Third Quarter 2024 Financial Results on April 9, 2024

Tilray Brands, Inc. to Announce Third Quarter 2024 Financial Results on April…